3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Uterine Cervical Neoplasms
8
Papillomavirus Infections
5
Uterine Cervical Dysplasia
4
Stomach Neoplasms
2
Atypical Squamous Cells of the Cervix
2
Uterine Neoplasms
1
Uterine Diseases
1
Uterine Cervical Diseases
1
Urogenital Neoplasms
1
Urogenital Diseases
1
Squamous Intraepithelial Lesions
1
Precancerous Conditions
1
Neoplasms by Site
1
Neoplasms
1
Genital Neoplasms, Female
1
Genital Diseases, Female
1
Genital Diseases
1
Female Urogenital Diseases and Pregnancy Complications
1
Anus Neoplasms
1
Interventions
pembrolizumab
5
Nivolumab
3
Cisplatin
3
Taxes
2
Paclitaxel
2
poly ICLC
1
fludarabine phosphate
1
fludarabine
1
abemaciclib
1
Risk Factors
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy
1
Radiation
1
Pemetrexed
1
Nimorazole
1
Injections
1
High-Intensity Focused Ultrasound Ablation
1
Erlotinib Hydrochloride
1
Docetaxel
1
Cyclophosphamide
1
Cetuximab
1
Carboplatin
1
Biological Products
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasms, Squamous Cell
×
Human Papillomavirus DNA Tests
×
1 year
×
Clear all
No trials found.